Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Company Description (as filed with the SEC)
Venaxis® is an in vitro diagnostic company focused on obtaining clearance from the U.S. Food and Drug Administration (FDA) for, and commercializing its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis (AA) in children adolescent and young adult patients. Our business strategy is to focus on products and technologies we believe have attractive worldwide markets and significant product margin potential. We may also pursue complementary and supporting technologies under strategic relationships as well as "in-licensing" agreements with third parties, and are in the initial stages of next generation product development. Our current test, the APPY1 Test, is a CE marked rapid blood test panel for aiding in identifying patients in the emergency department (ED) who are at low risk for acute appendicitis. ... More ...
Where does APPY fit in the risk graph?
|Annual EPS Est:||$|
|Quarterly EPS Est:|